The present study aimed to determine the pharmacokinetic parameters and bioavailability of silymarin 140 mg SMEDDS formulation. An open-label, single-dose pharmacokinetic study was conducted. Twelve healthy volunteers were included in the study.
View Article and Find Full Text PDFObjective: To perform a bioequivalence study of the two 1.5 g cefoperazone (1.0 g) and sulbactam (0.
View Article and Find Full Text PDF